Income tax expense · 2021–2025
Arcus Biosciences income tax expense
$0−100.0% · FY2025
Arcus Biosciences (RCUS) reported $0 in income tax expense for fiscal 2025, −100.0% year on year.
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arcus Biosciences income tax expense |url=https://companiesranked.com/en/company/arcus-biosciences/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arcus Biosciences income tax expense. CompaniesRanked. https://companiesranked.com/en/company/arcus-biosciences/income-tax-expenseBibTeX
@misc{companiesranked-en-company-arcus-biosciences-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Arcus Biosciences income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arcus-biosciences/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001724521-26-000009 · February 25, 2026
{{cite web |title=Arcus Biosciences income tax expense — 10-K (0001724521-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1724521/000172452126000009/rcus-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.